Investigating and novel strategies in vaccines and immunization

Image

The goal of public health is to prevent disease. It's much easier and more cost-effective to prevent a disease than to treat it. That's exactly what immunizations aim to do. Immunizations, or vaccines as they're also known, safely and effectively use a small amount of a weakened or killed virus or bacteria or bits of lab-made protein that imitate the virus in order to prevent infection by that same virus or bacteria.

 Pathology and Immunology:

Immunopathology is a branch of medicine that deals with immune responses associated with the disease. It incorporates the investigation of the pathology of a life form, organ framework, or ailment concerning the insusceptible framework, invulnerability, and resistant reactions. In science, it alludes to the harm caused to a creature by its own resistant reaction, because of a contamination. Two decade of clinical involvement with immunomodulatory medicines for various sclerosis points to unmistakable immunological pathways that drive ailment backslides and movement. Immunopathology could allude to how the outside antigens cause the invulnerable framework to have a reaction or issues that can emerge from a living being's own particular resistant reaction on itself. There are sure issues or blames in the invulnerable framework that can prompt more genuine sickness or malady.

 Human Vaccines-infectious & non- infectious:

Infectious diseases, including HIV/AIDS, tuberculosis(TB), malaria, poliomyelitis, and some others tropical diseases (NTDs) are rapidly spread out through communication(verbal), water, and wind. It also transmitted by vectors (mosquitoes, flies) and a major issue in developing countries. In the past, infectious diseases had been widely spread-out in developing countries and chronic diseases were found primarily in high-income countries. However, the global pattern of disease burden is shifting. While infectious disease still remains a major problem in many countries, chronic diseases, including such non-communicable conditions as cardiovascular disease, cancer, diabetes, and respiratory disease, are now the major cause of death and disability, not only in developed countries but also worldwide.

 Infection and Immunity:

The invasion of foreign organism on a host body for its growth and multiplication is termed as infection. The infection can lead to infectious diseases/ transmissible disease/ communicable disease. The infection can be caused by any infectious agents and their toxins causing several immune reactions like allergy, inflammation etc. Immune or allergic reactions arise upon infection due to the role of Host immune system to maintain immunity in the body. The infectious agents may be bacteria, virus, fungus, parasites, protozoans etc. As the agents vary, so does the route of transmission to enter into the host body and also the diseases, diagnosis and treatments.

 Veterinary Vaccine:

The main goal to produce the veterinary vaccine is to improve the health of the animals also its welfare. By increasing the production of veterinary vaccines, the animal to human transmitted diseases from both domestic and wildlife can be prevented. Commonly the dog vaccines (Vaccines for canine parvovirus, canine hepatitis and rabies are considered core vaccines. Non-core vaccines are given depending on the dog's exposure risk. These include vaccines against Bordetella bronchiseptica, Borrelia burgdorferi, and Leptospira bacteria are as popular as the veterinary vaccine. The infectious diseases that get transmitted to humans from animals can be prevented

 Open access planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.

 A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.

Manuscripts can be forwarded to the Editorial Office at autoimmunedis@eclinicalsci.com

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.

 

Media Contact:
John Kimberly
Editorial Manager
Journal of Vaccines & Vaccination
Email: jvv@scholarlypub.com